• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MeCP2 通过 miR-199a 介导的抑制 BMP-Smad 信号通路来控制神经干细胞命运特化。

MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling.

机构信息

Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.

Group of Brain Function and Development, Nagoya University Neuroscience Institute of the Graduate School of Science, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan; Research Unit for Developmental Disorders, Institute for Advanced Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan.

出版信息

Cell Rep. 2021 May 18;35(7):109124. doi: 10.1016/j.celrep.2021.109124.

DOI:10.1016/j.celrep.2021.109124
PMID:34010654
Abstract

Rett syndrome (RTT) is a severe neurological disorder, with impaired brain development caused by mutations in MECP2; however, the underlying mechanism remains elusive. We know from previous work that MeCP2 facilitates the processing of a specific microRNA, miR-199a, by associating with the Drosha complex to regulate neuronal functions. Here, we show that the MeCP2/miR-199a axis regulates neural stem/precursor cell (NS/PC) differentiation. A shift occurs from neuronal to astrocytic differentiation of MeCP2- and miR-199a-deficient NS/PCs due to the upregulation of a miR-199a target, Smad1, a downstream transcription factor of bone morphogenetic protein (BMP) signaling. Moreover, miR-199a expression and treatment with BMP inhibitors rectify the differentiation of RTT patient-derived NS/PCs and development of brain organoids, respectively, suggesting that facilitation of BMP signaling accounts for the impaired RTT brain development. Our study illuminates the molecular pathology of RTT and reveals the MeCP2/miR-199a/Smad1 axis as a potential therapeutic target for RTT.

摘要

雷特综合征(RTT)是一种严重的神经发育障碍,由 MECP2 基因突变引起大脑发育受损;然而,其潜在的机制仍难以捉摸。我们从之前的工作中了解到,MeCP2 通过与 Drosha 复合物结合来促进特定 microRNA(miR-199a)的加工,从而调节神经元功能。在这里,我们表明 MeCP2/miR-199a 轴调节神经干细胞/前体细胞(NS/PC)分化。由于骨形态发生蛋白(BMP)信号转导的下游转录因子 Smad1 的上调,MeCP2 和 miR-199a 缺陷的 NS/PC 发生从神经元到星形胶质细胞分化的转变。此外,miR-199a 的表达和 BMP 抑制剂的处理分别纠正了 RTT 患者来源的 NS/PC 的分化和脑类器官的发育,这表明促进 BMP 信号转导解释了 RTT 大脑发育受损的原因。我们的研究阐明了 RTT 的分子病理学,并揭示了 MeCP2/miR-199a/Smad1 轴作为 RTT 的潜在治疗靶点。

相似文献

1
MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling.MeCP2 通过 miR-199a 介导的抑制 BMP-Smad 信号通路来控制神经干细胞命运特化。
Cell Rep. 2021 May 18;35(7):109124. doi: 10.1016/j.celrep.2021.109124.
2
miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.微小RNA-199a将甲基化CpG结合蛋白2与雷帕霉素靶蛋白信号通路联系起来,其失调会导致雷特综合征表型。
Cell Rep. 2015 Sep 22;12(11):1887-901. doi: 10.1016/j.celrep.2015.08.028. Epub 2015 Sep 3.
3
MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid.MeCP2 功能障碍可阻止脑类器官中 BMP 信号的正常传递和神经祖细胞的扩增。
Ann Clin Transl Neurol. 2023 Jul;10(7):1170-1185. doi: 10.1002/acn3.51799. Epub 2023 Jun 11.
4
MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.MeCP2 调控的 microRNAs 通过对 ERK 和 AKT 信号通路的不同影响来控制早期人类神经发生。
Mol Psychiatry. 2018 Apr;23(4):1051-1065. doi: 10.1038/mp.2017.86. Epub 2017 Apr 25.
5
Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.源自雷特综合征患者的多能神经干细胞的分化偏向于星形胶质细胞谱系。
Mol Brain. 2015 May 27;8:31. doi: 10.1186/s13041-015-0121-2.
6
Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.具有功能性 MeCP2 剂量依赖性的雷特综合征的分级和全神经元疾病表型。
Protein Cell. 2021 Aug;12(8):639-652. doi: 10.1007/s13238-020-00773-z. Epub 2020 Aug 27.
7
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.分化抑制因子(ID1、ID2、ID3和ID4)基因是MeCP2的神经元靶点,在瑞特综合征中会升高。
Hum Mol Genet. 2006 Jun 15;15(12):2003-14. doi: 10.1093/hmg/ddl124. Epub 2006 May 8.
8
Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives.利用人类多能干细胞建立雷特综合征模型:机制研究结果与未来临床展望
Int J Mol Sci. 2021 Apr 3;22(7):3751. doi: 10.3390/ijms22073751.
9
MicroRNA-197 controls ADAM10 expression to mediate MeCP2's role in the differentiation of neuronal progenitors.微小 RNA-197 控制 ADAM10 的表达,从而介导 MeCP2 在神经元祖细胞分化中的作用。
Cell Death Differ. 2019 Oct;26(10):1863-1879. doi: 10.1038/s41418-018-0257-6. Epub 2018 Dec 18.
10
CREB Signaling Is Involved in Rett Syndrome Pathogenesis.CREB信号传导参与瑞特综合征的发病机制。
J Neurosci. 2017 Mar 29;37(13):3671-3685. doi: 10.1523/JNEUROSCI.3735-16.2017. Epub 2017 Mar 7.

引用本文的文献

1
MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies.雷特综合征中的MECP2功能障碍:分子机制、多系统病理学及新兴治疗策略
Int J Mol Sci. 2025 Aug 26;26(17):8277. doi: 10.3390/ijms26178277.
2
BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling.骨形态发生蛋白10通过ALK2/ smad1/5/8信号通路加速神经性疼痛中的脊髓星形胶质细胞激活。
Front Pharmacol. 2024 Aug 12;15:1426121. doi: 10.3389/fphar.2024.1426121. eCollection 2024.
3
Early differential impact of MeCP2 mutations on functional networks in Rett syndrome patient-derived human cerebral organoids.
MeCP2突变对雷特综合征患者来源的人脑类器官功能网络的早期差异影响。
bioRxiv. 2024 Aug 10:2024.08.10.607464. doi: 10.1101/2024.08.10.607464.
4
Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential.靶向淀粉样β蛋白介导的阿尔茨海默病病理生理过程中的表观遗传机制:揭示治疗潜力。
Neural Regen Res. 2025 Jan 1;20(1):54-66. doi: 10.4103/NRR.NRR-D-23-01827. Epub 2024 Mar 1.
5
Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort.血浆微小RNA作为约旦队列中精神分裂症的潜在生物标志物。
Noncoding RNA Res. 2024 Jan 30;9(2):350-358. doi: 10.1016/j.ncrna.2024.01.018. eCollection 2024 Jun.
6
Variable expression of and in the human brain: Implications for gene restorative therapies.在人脑内可变表达的 和 :对基因修复治疗的启示。
Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2312757121. doi: 10.1073/pnas.2312757121. Epub 2024 Feb 22.
7
Comprehensive Transcriptomic Investigation of Rett Syndrome Reveals Increasing Complexity Trends from Induced Pluripotent Stem Cells to Neurons with Implications for Enriched Pathways.雷特综合征的综合转录组学研究揭示了从诱导多能干细胞到神经元的复杂性增加趋势及其对富集通路的影响。
ACS Omega. 2023 Nov 8;8(46):44148-44162. doi: 10.1021/acsomega.3c06448. eCollection 2023 Nov 21.
8
Analysis of the interplay between MeCP2 and histone H1 during differentiation of human ReNCell neural progenitor cells.分析 MeCP2 与组蛋白 H1 之间的相互作用在人 ReNCell 神经祖细胞分化过程中的作用。
Epigenetics. 2023 Dec;18(1):2276425. doi: 10.1080/15592294.2023.2276425. Epub 2023 Nov 17.
9
MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid.MeCP2 功能障碍可阻止脑类器官中 BMP 信号的正常传递和神经祖细胞的扩增。
Ann Clin Transl Neurol. 2023 Jul;10(7):1170-1185. doi: 10.1002/acn3.51799. Epub 2023 Jun 11.
10
KW-2449 and VPA exert therapeutic effects on human neurons and cerebral organoids derived from MECP2-null hESCs.KW-2449 和 VPA 对源自 MECP2 基因敲除 hESC 的人神经元和脑类器官具有治疗作用。
Stem Cell Res Ther. 2022 Dec 27;13(1):534. doi: 10.1186/s13287-022-03216-0.